Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis A Gimotty

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2024
Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti-PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free SurvivalKevin L Ma, Tara C Mitchell, Meaghan Dougher, et al.
CA: a Cancer Journal for Clinicians|January 20, 2016
American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicineMichael W Kattan, Kenneth R Hess, Mahul B Amin, et al.
Annals of Surgical Oncology|May 3, 2005
Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomasSusan B Kesmodel, Giorgos C Karakousis, Jeffrey D Botbyl, et al.
Cancer Research|May 6, 2017
Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human CancerDongmei Zhang, Gao Zhang, Xiaowen Hu, et al.
Science Immunology|April 8, 2018
The receptor repertoire and functional profile of follicular T cells in HIV-infected lymph nodesBen S Wendel, Daniel Del Alcazar, Chenfeng He, et al.
Cancer Cell|June 15, 2013
Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cellsAlexander Roesch, Adina Vultur, Ivan Bogeski, et al.
Oncotarget|July 25, 2016
PIM kinases as therapeutic targets against advanced melanomaBatool Shannan, Andrea Watters, Quan Chen, et al.
Developmental Cell|January 27, 2022
ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppressionWei Zhang, Wenqun Zhong, Beike Wang, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
The Journal of Experimental Medicine|March 10, 2020
Trib1 regulates T cell differentiation during chronic infection by restraining the effector programKelly S Rome, Sarah J Stein, Makoto Kurachi, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2024
Tumor-Infiltrating Lymphocytes in Necrotic Tumors after Melanoma Neoadjuvant Anti-PD-1 Therapy Correlate with Pathologic Response and Recurrence-Free SurvivalKevin L Ma, Tara C Mitchell, Meaghan Dougher, et al.
CA: a Cancer Journal for Clinicians|January 20, 2016
American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicineMichael W Kattan, Kenneth R Hess, Mahul B Amin, et al.
Annals of Surgical Oncology|May 3, 2005
Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomasSusan B Kesmodel, Giorgos C Karakousis, Jeffrey D Botbyl, et al.
Cancer Research|May 6, 2017
Oncogenic RAS Regulates Long Noncoding RNA <i>Orilnc1</i> in Human CancerDongmei Zhang, Gao Zhang, Xiaowen Hu, et al.
Science Immunology|April 8, 2018
The receptor repertoire and functional profile of follicular T cells in HIV-infected lymph nodesBen S Wendel, Daniel Del Alcazar, Chenfeng He, et al.
Cancer Cell|June 15, 2013
Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cellsAlexander Roesch, Adina Vultur, Ivan Bogeski, et al.
Oncotarget|July 25, 2016
PIM kinases as therapeutic targets against advanced melanomaBatool Shannan, Andrea Watters, Quan Chen, et al.
Developmental Cell|January 27, 2022
ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppressionWei Zhang, Wenqun Zhong, Beike Wang, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytesSarah F Adams, Alizée J Grimm, Cheryl L-L Chiang, et al.
The Journal of Experimental Medicine|March 10, 2020
Trib1 regulates T cell differentiation during chronic infection by restraining the effector programKelly S Rome, Sarah J Stein, Makoto Kurachi, et al.
Pageof 15